Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study

OBJECTIVE: To evaluate the efficacy and safety of USL255, Qudexy™ XR (topiramate) extended-release capsules, as an adjunctive treatment for refractory partial-onset seizures (POS) in adults taking one to three concomitant antiepileptic drugs. METHODS: In this global phase III study (PREVAIL; NCT0114...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chung, Steve S, Fakhoury, Toufic A, Hogan, R Edward, Nagaraddi, Venkatesh N, Blatt, Ilan, Lawson, Balduin, Arnold, Stephan, Anders, Bob, Clark, Annie M, Laine, Dawn, Meadows, R Shawn, Halvorsen, Mark B
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2014
Assuntos:
Full-Length Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4143954/
https://ncbi.nlm.nih.gov/pubmed/24902983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.12660
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados